1. Home
  2. GRDN vs GIII Comparison

GRDN vs GIII Comparison

Compare GRDN & GIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRDN
  • GIII
  • Stock Information
  • Founded
  • GRDN 2004
  • GIII 1956
  • Country
  • GRDN United States
  • GIII United States
  • Employees
  • GRDN N/A
  • GIII N/A
  • Industry
  • GRDN Retail-Drug Stores and Proprietary Stores
  • GIII Apparel
  • Sector
  • GRDN Consumer Staples
  • GIII Consumer Discretionary
  • Exchange
  • GRDN Nasdaq
  • GIII Nasdaq
  • Market Cap
  • GRDN 1.2B
  • GIII 1.4B
  • IPO Year
  • GRDN 2024
  • GIII 1989
  • Fundamental
  • Price
  • GRDN $20.97
  • GIII $27.48
  • Analyst Decision
  • GRDN Strong Buy
  • GIII Buy
  • Analyst Count
  • GRDN 2
  • GIII 6
  • Target Price
  • GRDN $22.50
  • GIII $33.17
  • AVG Volume (30 Days)
  • GRDN 103.7K
  • GIII 732.1K
  • Earning Date
  • GRDN 03-26-2025
  • GIII 03-13-2025
  • Dividend Yield
  • GRDN N/A
  • GIII N/A
  • EPS Growth
  • GRDN N/A
  • GIII 12.00
  • EPS
  • GRDN N/A
  • GIII 4.20
  • Revenue
  • GRDN $1,228,409,000.00
  • GIII $3,180,796,000.00
  • Revenue This Year
  • GRDN $18.62
  • GIII $0.73
  • Revenue Next Year
  • GRDN $9.51
  • GIII N/A
  • P/E Ratio
  • GRDN N/A
  • GIII $6.51
  • Revenue Growth
  • GRDN 17.42
  • GIII 2.67
  • 52 Week Low
  • GRDN $14.16
  • GIII $20.66
  • 52 Week High
  • GRDN $25.74
  • GIII $36.18
  • Technical
  • Relative Strength Index (RSI)
  • GRDN N/A
  • GIII 51.60
  • Support Level
  • GRDN N/A
  • GIII $26.53
  • Resistance Level
  • GRDN N/A
  • GIII $27.96
  • Average True Range (ATR)
  • GRDN 0.00
  • GIII 1.28
  • MACD
  • GRDN 0.00
  • GIII 0.26
  • Stochastic Oscillator
  • GRDN 0.00
  • GIII 42.41

About GRDN Guardian Pharmacy Services Inc. Class A Common Stock

Guardian Pharmacy Services Inc is a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs, and .BHFs.

About GIII G-III Apparel Group LTD.

G-III Apparel Group Ltd is a textile company. It makes a wide range of apparel, footwear, and accessories that it sells under its own brands, licensed brands, and private-label brands. G-III has a substantial portfolio for licensed and proprietary brands, anchored by five global power brands: DKNY, Donna Karan, Calvin Klein, Tommy Hilfiger, and Karl Lagerfeld. The company has two reportable operations: Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, as well as sales of products under its own brands and private label brands. The retail operations segment consists primarily of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives most of its revenues from Wholesale operations.

Share on Social Networks: